Isosteviol

Isosteviol

SCHEMBL3489810

C[C@@]12CC[C@@H]3[C@@](CC[C@H]4[C@@]3(C)CCC[C@@]4(C)C(=O)O)(CC1=O)C2

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Full drug profile on Sugi Atlas →

Predicted protein targets (top 8)

geneUniProtsupporting neighboursconfidence
F10 P00742 9/20 1.00
PTPN1 P18031 5/20 1.00
PTPN2 P17706 3/20 1.00
CDC25B P30305 3/20 1.00
BCHE P06276 4/20 0.64
L3MBTL1 Q9Y468 1/20 0.64
ACHE P22303 4/20 0.59
HSD11B1 P28845 1/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Isosteviol SCHEMBL22922207 1.00 F10 (1.00) F10PTPN1PTPN2CDC25BBCHE
Isosteviol SCHEMBL13401648 1.00 F10 (1.00) F10PTPN1PTPN2CDC25BBCHE
Isosteviol SCHEMBL439433 1.00 F10 (1.00) F10PTPN1PTPN2CDC25BBCHE
Isosteviol SCHEMBL2987296 1.00 F10 (1.00) F10PTPN1PTPN2CDC25BBCHE
Isosteviol SCHEMBL14925190 1.00 F10 (1.00) F10PTPN1PTPN2CDC25BBCHE
Isosteviol SCHEMBL2025230 1.00 F10 (1.00) F10PTPN1PTPN2CDC25BBCHE
Isosteviol SCHEMBL26990273 1.00 F10 (1.00) F10PTPN1PTPN2CDC25BBCHE
Isosteviol SCHEMBL13401807 1.00 F10 (1.00) F10PTPN1PTPN2CDC25BBCHE
SCHEMBL17066125 0.87 F10 (0.77) F10PTPN1PTPN2CDC25BBCHE
SCHEMBL13242208 0.87 F10 (0.77) F10PTPN1PTPN2CDC25BBCHE

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 107 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-114933554-B Isotevelol-based injectable supermolecular hydrogel and preparation method and application thereof 新乡医学院 2023-09-29 CN claimed
EP-3191438-B1 SWEETNESS ENHANCER PEPSICO INC (US) 2021-12-15 EP claimed
US-10966447-B2 Glucosyringic acid analogs as sweetness profile modifiers PEPSICO, INC. (US) 2021-04-06 US claimed
US-10932483-B2 Sweetness enhancer PEPSICO, INC. (US) 2021-03-02 US claimed
EP-3487318-A1 GLUCOSYRINGIC ACID ANALOGS AS SWEETNESS PROFILE MODIFIERS Pepsico, Inc. (US) 2019-05-29 EP claimed
EP-3485019-A1 REBAUDIOSIDE ANALOGS Pepsico, Inc. (US) 2019-05-22 EP claimed
US-20180020708-A1 GLUCOSYRINGIC ACID ANALOGS AS SWEETNESS PROFILE MODIFIERS PEPSICO, INC. 2018-01-25 US claimed
WO-2018017574-A1 GLUCOSYRINGIC ACID ANALOGS AS SWEETNESS PROFILE MODIFIERS PEPSICO, INC. (US) 2018-01-25 WO claimed
US-20180016291-A1 Rebaudioside Analogs PEPSICO, INC. 2018-01-18 US claimed
WO-2018013767-A1 REBAUDIOSIDE ANALOGS PEPSICO, INC. (US) 2018-01-18 WO claimed
US-20170245537-A1 Sweetness Enhancer PEPSICO, INC. 2017-08-31 US claimed
EP-3191438-A1 SWEETNESS ENHANCER Pepsico, Inc. (US) 2017-07-19 EP claimed
WO-2016040577-A1 SWEETNESS ENHANCER PEPSICO, INC. (US) 2016-03-17 WO claimed
WO-2007149679-A2 METHOD OF DELIVERING AN ACTIVE COMPONENT TO A LIQUID FOODSTUFF IN A CONTAINER WITH A NARROW OPENING MCNEIL NUTRITIONALS, LLC (US) 2007-12-27 WO claimed
WO-2007140295-A2 METHOD OF DELIVERING A HIGH INTENSITY SWEETENER TO A LIQUID FOODSTUFF MCNEIL NUTRITIONALS, LLC (US) 2007-12-06 WO claimed
US-20070275125-A1 METHOD OF DELIVERING AN ACTIVE COMPONENT TO A LIQUID FOODSTUFF IN A CONTAINER WITH A NARROW OPENING MCNEIL NUTRITIONALS, LLC 2007-11-29 US claimed
US-20070275145-A1 METHOD OF DELIVERING A HIGH INTENSITY SWEETENER TO A LIQUID FOODSTUFF MCNEIL NUTRITIONALS, LLC 2007-11-29 US claimed
US-20070275146-A1 METHOD OF AND DEVICE FOR DELIVERING AN ACTIVE COMPONENT TO A LIQUID FOODSTUFF MCNEIL NUTRITIONALS, LLC 2007-11-29 US claimed
EP-0565785-A1 Use of glucose transport inhibitors for the treatment for acne Leveen, Harry H. (US) 1993-10-20 EP claimed
US-20250333535-A1 BISPECIFIC SINGLE CHAIN ANTIBODY CONSTRUCT WITH ENHANCED TISSUE DISTRIBUTION AMGEN RES MUNICH GMBH (DE) 2025-10-30 US disclosed
CN-115997912-B Steviol glycoside compositions with improved flavor profile 伊比西(北京)植物药物技术有限公司 2025-05-13 CN disclosed
CN-118754831-A Isostanol sulfonamide derivative, preparation method and application 郑州工程技术学院 2024-10-11 CN disclosed
EP-3174903-B1 BISPECIFIC SINGLE CHAIN ANTIBODY CONSTRUCT WITH ENHANCED TISSUE DISTRIBUTION AMGEN RES MUNICH GMBH (DE) 2024-04-10 EP disclosed
US-20240108042-A1 COMPOSITIONS AND METHODS FOR ENHANCING SWEETNESS PEPSICO INC (US) 2024-04-04 US disclosed
US-11914069-B2 System and MMIC architecture for coherent multi-chip phased array MIMO applications INFINEON TECHNOLOGIES AG (DE) 2024-02-27 US disclosed
US-11849742-B2 Tasteful natural sweetener and flavor EPC NATURAL PRODUCTS CO., LTD. (CN) 2023-12-26 US disclosed
US-20230363424-A1 COMPOUNDS AND METHODS FOR ENHANCING SWEETNESS OF SWEETENERS CONAGEN INC. (US) 2023-11-16 US disclosed
EP-4274426-A1 COMPOUNDS AND METHODS FOR ENHANCING SWEETNESS OF SWEETENERS Conagen Inc. (US) 2023-11-15 EP disclosed
US-11751593-B2 Sweetener and flavor compositions, methods of making and methods of use thereof EPC Natural Products Co., Ltd (CN) 2023-09-12 US disclosed
CN-112135527-B Steviol glycoside compositions with improved flavor 伊比西(北京)植物药物技术有限公司 2023-08-15 CN disclosed
US-20230232878-A1 COMPOSITIONS COMPRISING REBAUDIOSIDE J PEPSICO, INC. (US) 2023-07-27 US disclosed
CN-116283562-A Isosteviol derivative and application thereof in preparation of antitumor drugs 上海海洋大学 2023-06-23 CN disclosed
CN-115997912-A Steviol glycoside compositions with improved flavor profile 伊比西(北京)植物药物技术有限公司 2023-04-25 CN disclosed
US-11582993-B2 Compositions comprising rebaudioside J PEPSICO, INC. (US) 2023-02-21 US disclosed
US-20230049373-A1 PASTE-LIKE COMPOSITION FOR DENTAL USE, AND METHOD FOR PRODUCING THE SAME KURARAY NORITAKE DENTAL INC. (JP) 2023-02-16 US disclosed
US-11579280-B2 Phase, phase noise, and slave mode measurement for millimeter wave integrated circuits on automatic test equipment INFINEON TECHNOLOGIES AG (DE) 2023-02-14 US disclosed
EP-4082514-A1 PASTE-LIKE COMPOSITION FOR DENTAL USE, AND METHOD FOR PRODUCING THE SAME Kuraray Noritake Dental Inc. (JP) 2022-11-02 EP disclosed
WO-2022221250-A1 NOVEL COMPOSITIONS FOR TASTE MASKING INTERNATIONAL FLAVORS & FRAGRANCES INC. (US) 2022-10-20 WO disclosed
WO-2022150445-A1 COMPOUNDS AND METHODS FOR ENHANCING SWEETNESS OF SWEETENERS CONAGEN INC. (US) 2022-07-14 WO disclosed
US-20220196796-A1 SYSTEM AND MMIC ARCHITECTURE FOR COHERENT MULTI-CHIP PHASED ARRAY MIMO APPLICATIONS INFINEON TECHNOLOGIES AG (DE) 2022-06-23 US disclosed
CN-114646960-A System and MMIC architecture for coherent multi-chip phased array MIMO applications 英飞凌科技股份有限公司 2022-06-21 CN disclosed
US-20210392915-A1 PLANT-BASED CHOCOLATE WITH SESAME COMPONENT AND METHOD FOR MAKING SAME SUADELLA CHOCOLATIER LLC 2021-12-23 US disclosed
US-20210386104-A1 WATER SOLUBLE FLAVOR COMPOSITIONS, METHODS OF MAKING AND METHODS OF USE THEREOF EPC Natural Products Co., Ltd (CN) 2021-12-16 US disclosed
EP-3191438-B1 SWEETNESS ENHANCER PEPSICO INC (US) 2021-12-15 EP disclosed
EP-3863428-A1 WATER SOLUBLE FLAVOR COMPOSITIONS, METHODS OF MAKING AND METHODS OF USE THEREOF EPC Natural Products Co., Ltd. (CN) 2021-08-18 EP disclosed
US-20210147831-A1 SEQUENCING-BASED PROTEOMICS THE BROAD INSTITUTE, INC. (US) 2021-05-20 US disclosed
EP-3813545-A1 STEVIOL GLYCOSIDE COMPOSITIONS WITH IMPROVED FLAVOR EPC Natural Products Co., Ltd. (CN) 2021-05-05 EP disclosed
EP-3801050-A1 A NATURALLY SWEET ENHANCER COMPOSITION EPC Natural Products Co., Ltd. (CN) 2021-04-14 EP disclosed
US-10966447-B2 Glucosyringic acid analogs as sweetness profile modifiers PEPSICO, INC. (US) 2021-04-06 US disclosed
EP-3784236-A1 READY-TO-DRINK PLANT PROTEIN BEVERAGE PRODUCT AND METHODS FOR MAKING SAME Stokely-Van Camp, Inc. (US) 2021-03-03 EP disclosed
US-10932483-B2 Sweetness enhancer PEPSICO, INC. (US) 2021-03-02 US disclosed
US-10806165-B2 Ready-to-drink plant protein beverage product and methods for making same STOKELY-VAN CAMP, INC. (US) 2020-10-20 US disclosed
US-20200138071-A1 SWEETENER AND FLAVOR COMPOSITIONS, METHODS OF MAKING AND METHODS OF USE THEREOF EPC Natural Products Co., Ltd (CN) 2020-05-07 US disclosed
US-20200093165-A1 NATURALLY SWEET ENHANCER COMPOSITION EPC NATURAL PRODUCTS CO., LTD. (CN) 2020-03-26 US disclosed
US-20200054056-A1 TASTEFUL NATURAL SWEETENER AND FLAVOR EPC NATURAL PRODUCTS CO., LTD. (CN) 2020-02-20 US disclosed
US-20200029608-A1 COMPOSITIONS AND METHODS FOR ENHANCING SWEETNESS PEPSICO, INC. 2020-01-30 US disclosed
WO-2019238010-A1 A NATURALLY SWEET ENHANCER COMPOSITION EPC NATURAL PRODUCTS CO., LTD. (CN) 2019-12-19 WO disclosed
WO-2019217467-A1 STEVIOL GLYCOSIDE COMPOSITIONS WITH IMPROVED FLAVOR EPC NATURAL PRODUCTS CO., LTD. (CN) 2019-11-14 WO disclosed
US-20190320689-A1 Ready-To-Drink Plant Protein Beverage Product and Methods for Making Same STOKELY-VAN CAMP, INC. 2019-10-24 US disclosed
US-20190313670-A1 Flavor-Enhanced Beverage Product and Method of Enhancing the Flavor Thereof FRITO LAY NORTH AMERICA INC (US) 2019-10-17 US disclosed
US-20190307154-A1 STEVIOL GLYCOSIDE COMPOSITIONS WITH IMPROVED FLAVOR EPC NATURAL PRODUCTS CO., LTD. (CN) 2019-10-10 US disclosed
US-10375976-B2 Flavor-enhanced beverage product and method of enhancing the flavor thereof FRITO-LAY NORTH AMERICA, INC. (US) 2019-08-13 US disclosed
EP-3503743-A1 COMPOSITIONS COMPRISING REBAUDIOSIDE J Pepsico, Inc. (US) 2019-07-03 EP disclosed
US-20190174806-A1 COMPOSITIONS COMPRISING REBAUDIOSIDE J PEPSICO, INC. (US) 2019-06-13 US disclosed
EP-3487318-A1 GLUCOSYRINGIC ACID ANALOGS AS SWEETNESS PROFILE MODIFIERS Pepsico, Inc. (US) 2019-05-29 EP disclosed
EP-3485019-A1 REBAUDIOSIDE ANALOGS Pepsico, Inc. (US) 2019-05-22 EP disclosed
US-20190124953-A1 NOVEL STEVIOL GLYCOSIDES BLENDS PEPSICO, INC. (US) 2019-05-02 US disclosed
WO-2019079401-A1 AGGLOMERATE BEVERAGE MODIFIER COMPRISING WHOLE GRAINS, METHOD OF PRODUCING THE AGGLOMERATE AND MILK-BASED BEVERAGE COMPRISING SAME THE QUAKER OATS COMPANY (US) 2019-04-25 WO disclosed
US-20190110507-A1 AGGLOMERATE BEVERAGE MODIFIER COMPRISING WHOLE GRAINS, METHOD OF PRODUCING THE AGGLOMERATE AND MILK-BASED BEVERAGE COMPRISING SAME THE QUAKER OATS COMPANY 2019-04-18 US disclosed
EP-3440184-A1 A FLAVOR-ENHANCED BEVERAGE PRODUCT AND METHOD OF ENHANCING THE FLAVOR THEREOF Frito-Lay North America, Inc. (US) 2019-02-13 EP disclosed
US-10085472-B2 Compositions comprising rebaudioside J PEPSICO, INC. (US) 2018-10-02 US disclosed
WO-2018157035-A1 COMPOSITIONS AND METHODS FOR ENHANCING SWEETNESS PEPSICO, INC. (US) 2018-08-30 WO disclosed
US-20180214400-A1 THE USE OF KAURANES COMPOUNDS IN THE MANUFACTURE OF MEDICAMENT FOR TREATMENT OF CADIAC HYPERTROPY AND PULMONARY HYPERTENSION TAN WEN (CN) 2018-08-02 US disclosed
WO-2018067503-A1 MOUTHFEEL BLENDS FOR LOW AND NON-CALORIC BEVERAGES PEPSICO, INC. (US) 2018-04-12 WO disclosed
US-20180092381-A1 MOUTHFEEL BLENDS FOR LOW AND NON-CALORIC BEVERAGES PEPSICO, INC. (US) 2018-04-05 US disclosed
WO-2018044588-A1 COMPOSITIONS COMPRISING REBAUDIOSIDE J PEPSICO, INC. (US) 2018-03-08 WO disclosed
US-20180055080-A1 COMPOSITIONS COMPRISING REBAUDIOSIDE J PEPSICO, INC. 2018-03-01 US disclosed
US-20180020708-A1 GLUCOSYRINGIC ACID ANALOGS AS SWEETNESS PROFILE MODIFIERS PEPSICO, INC. 2018-01-25 US disclosed
WO-2018017574-A1 GLUCOSYRINGIC ACID ANALOGS AS SWEETNESS PROFILE MODIFIERS PEPSICO, INC. (US) 2018-01-25 WO disclosed
US-20180016291-A1 Rebaudioside Analogs PEPSICO, INC. 2018-01-18 US disclosed
WO-2018013767-A1 REBAUDIOSIDE ANALOGS PEPSICO, INC. (US) 2018-01-18 WO disclosed
WO-2017189994-A1 NOVEL STEVIOL GLYCOSIDES BLENDS PEPSICO, INC. (US) 2017-11-02 WO disclosed
WO-2017172966-A1 A FLAVOR-ENHANCED BEVERAGE PRODUCT AND METHOD OF ENHANCING THE FLAVOR THEREOF FRITO-LAY NORTH AMERICA, INC. (US) 2017-10-05 WO disclosed
US-20170280751-A1 Flavor-Enhanced Beverage Product and Method of Enhancing the Flavor Thereof FRITO-LAY NORTH AMERICA, INC. 2017-10-05 US disclosed
US-9770711-B2 General catalyst for C-H functionalization THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ILLINOIS (US) 2017-09-26 US disclosed
US-9770711-B2 General catalyst for C-H functionalization THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ILLINOIS (US) 2017-09-26 US disclosed
US-20170245537-A1 Sweetness Enhancer PEPSICO, INC. 2017-08-31 US disclosed
EP-3191438-A1 SWEETNESS ENHANCER Pepsico, Inc. (US) 2017-07-19 EP disclosed
US-9687434-B2 Cosmetic use of steviol, of a steviol glycoside derivative or of one of their isomers to stimulate, restore or regulate the metabolism of the cells of the skin and semimucus membranes L'OREAL (FR) 2017-06-27 US disclosed
US-20160272662-A1 GENERAL CATALYST FOR C-H FUNCTIONALIZATION THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ILLINOIS (US) 2016-09-22 US disclosed
US-20160272662-A1 GENERAL CATALYST FOR C-H FUNCTIONALIZATION THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ILLINOIS (US) 2016-09-22 US disclosed
WO-2016040577-A1 SWEETNESS ENHANCER PEPSICO, INC. (US) 2016-03-17 WO disclosed
US-9125877-B2 Use of kauranes compounds in the manufacture of medicament TAN WEN (US) 2015-09-08 US disclosed
US-9125877-B2 Use of kauranes compounds in the manufacture of medicament TAN WEN (US) 2015-09-08 US disclosed
CN-102731589-B Steviol glycoside isomers PEPSICO INC 2015-05-13 CN disclosed
US-20150011493-A1 COSMETIC USE OF STEVIOL, OF A STEVIOL GLYCOSIDE DERIVATIVE OR OF ONE OF THEIR ISOMERS TO STIMULATE, RESTORE OR REGULATE THE METABOLISM OF THE CELLS OF THE SKIN AND SEMIMUCUS MEMBRANES L'OREAL (FR) 2015-01-08 US disclosed
US-20150011493-A1 COSMETIC USE OF STEVIOL, OF A STEVIOL GLYCOSIDE DERIVATIVE OR OF ONE OF THEIR ISOMERS TO STIMULATE, RESTORE OR REGULATE THE METABOLISM OF THE CELLS OF THE SKIN AND SEMIMUCUS MEMBRANES L'OREAL (FR) 2015-01-08 US disclosed
EP-2155769-B1 TISSUE DEGENERATION PROTECTION UNIV LEUVEN KATH (BE) 2012-06-27 EP disclosed
US-20100179097-A1 Use of kauranes compounds in the manufacture of medicament TAN WEN 2010-07-15 US disclosed
US-20100112101-A1 BIO-AVAILABILITY/BIO-EFFICACY ENHANCING ACTIVITY OF STEVIA REBAUDIANA AND EXTRACTS AND FRACTIONS AND COMPOUNDS THEREOF LAILA IMPEX (IN) 2010-05-06 US disclosed
US-20100099640-A1 TISSUE DEGENERATION PROTECTION GEUNS JOANNES 2010-04-22 US disclosed
EP-2155769-A2 TISSUE DEGENERATION PROTECTION Katholieke Universiteit Leuven (BE) 2010-02-24 EP disclosed
WO-2008134828-A2 TISSUE DEGENERATION PROTECTION KATHOLIEKE UNIVERSITEIT LEUVEN (BE) 2008-11-13 WO disclosed
WO-2007149679-A2 METHOD OF DELIVERING AN ACTIVE COMPONENT TO A LIQUID FOODSTUFF IN A CONTAINER WITH A NARROW OPENING MCNEIL NUTRITIONALS, LLC (US) 2007-12-27 WO disclosed
US-20070275125-A1 METHOD OF DELIVERING AN ACTIVE COMPONENT TO A LIQUID FOODSTUFF IN A CONTAINER WITH A NARROW OPENING MCNEIL NUTRITIONALS, LLC 2007-11-29 US disclosed
US-20070275125-A1 METHOD OF DELIVERING AN ACTIVE COMPONENT TO A LIQUID FOODSTUFF IN A CONTAINER WITH A NARROW OPENING MCNEIL NUTRITIONALS, LLC 2007-11-29 US disclosed
US-20070275145-A1 METHOD OF DELIVERING A HIGH INTENSITY SWEETENER TO A LIQUID FOODSTUFF MCNEIL NUTRITIONALS, LLC 2007-11-29 US disclosed
US-20070275146-A1 METHOD OF AND DEVICE FOR DELIVERING AN ACTIVE COMPONENT TO A LIQUID FOODSTUFF MCNEIL NUTRITIONALS, LLC 2007-11-29 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (11 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160272662-A1 GENERAL CATALYST FOR C-H FUNCTIONALIZATION BET1, PLEC, NUDC F10 3671/4885PTPN1 4410/4885PTPN2 4604/4885
US-10966447-B2 Glucosyringic acid analogs as sweetness profile modifiers GPR119, TAS2R42, TAS2R31 F10 2321/4885PTPN1 2400/4885PTPN2 2483/4885
US-20150011493-A1 COSMETIC USE OF STEVIOL, OF A STEVIOL GLYCOSIDE DERIVATIVE OR OF ONE OF THEIR ISOMERS TO STIMULATE, RESTORE OR REGULATE THE METABOLISM OF THE CELLS OF THE SKIN AND SEMIMUCUS MEMBRANES CUTA, SUCNR1, ARG2 F10 3268/4885PTPN1 2331/4885PTPN2 1192/4885
US-20180016291-A1 Rebaudioside Analogs SLC5A1, TAS1R1, FBP1 F10 1125/4885PTPN1 3702/4885PTPN2 4177/4885
US-20180020708-A1 GLUCOSYRINGIC ACID ANALOGS AS SWEETNESS PROFILE MODIFIERS GPR119, TAS2R42, TAS2R31 F10 2321/4885PTPN1 2400/4885PTPN2 2483/4885
US-20100179097-A1 Use of kauranes compounds in the manufacture of medicament KDM1A, KCNA1, KCNE1 F10 345/4885PTPN1 4497/4885PTPN2 4727/4885
US-20230049373-A1 PASTE-LIKE COMPOSITION FOR DENTAL USE, AND METHOD FOR PRODUCING THE SAME PFN1, XRN2, FLNA F10 706/4885PTPN1 3500/4885PTPN2 3255/4885
US-10932483-B2 Sweetness enhancer SLC5A1, SLC2A8, SLC5A2 F10 2164/4885PTPN1 2034/4885PTPN2 2590/4885
US-20170245537-A1 Sweetness Enhancer SLC5A1, SLC2A8, SLC5A2 F10 2164/4885PTPN1 2034/4885PTPN2 2590/4885
US-20180214400-A1 THE USE OF KAURANES COMPOUNDS IN THE MANUFACTURE OF MEDICAMENT FOR TREATMENT OF CADIAC HYPERTROPY AND PULMONARY HYPERTENSION ROS1, PRKG1, PRKCH F10 1758/4885PTPN1 4712/4885PTPN2 4732/4885
US-20100099640-A1 TISSUE DEGENERATION PROTECTION SORD, CASP3, TXNRD2 F10 551/4885PTPN1 3492/4885PTPN2 2958/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.